Merck (MRK) Tops Q3 EPS by 20c, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $148.78 +0.54%
EPS Growth %: -14.3%
Financial Fact:
Other (income) expense, net: -3.28B
Today's EPS Names:
OCCI, IPX, ALZN, More
EPS Growth %: -14.3%
Financial Fact:
Other (income) expense, net: -3.28B
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q3 EPS of $1.75, $0.20 better than the analyst estimate of $1.55. Revenue for the quarter came in at $13.2 billion versus the consensus estimate of $12.33 billion.
GUIDANCE:
Merck sees FY2021 EPS of $5.65-$5.70, versus the consensus of $5.77. Merck sees FY2021 revenue of $47.4-47.9 billion, versus the consensus of $48.16 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Paychex (PAYX) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
